Download
15010_2024_Article_2285.pdf 2,89MB
WeightNameValue
1000 Titel
  • Investigation of the pathogen-specific antibody response in periprosthetic joint infection
1000 Autor/in
  1. Janz, Viktor |
  2. Rakow, Anastasia |
  3. Schröder, Leonie |
  4. Hofer, André |
  5. Wiebe, Sergej |
  6. Schoon, Janosch |
  7. Weiss, Stefan |
  8. Bröker, Barbara M. |
  9. Wassilew, Georgi I. |
  10. Raafat, Dina |
1000 Verlag Springer Berlin Heidelberg
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-05-31
1000 Erschienen in
1000 Quellenangabe
  • 52(6):2325-2337
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s15010-024-02285-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11621160/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>Periprosthetic joint infections (PJIs) are a very demanding complication of arthroplasty. Diagnosis of PJI and pathogen identification pose considerable challenges in clinical practice. We hypothesized that the pathogen-specific immune response to PJI reflects the infection process, provides clinically relevant information on disease course, and has the potential to further optimize antimicrobial therapy.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>We conducted a prospective matched cohort pilot study with 13 patients undergoing two-stage septic revision arthroplasty (PJI patients) between 06/2020 and 06/2021, as well as 11 control patients undergoing one-stage aseptic revision arthroplasty (Non-PJI patients). Pre-, intra- and postoperative serum samples were collected at standardized time points. We developed a custom Luminex®-based quantitative bead-based suspension array (Infection Array; IA), and used it for simultaneous measurement of antibody specificities against 32 pathogens commonly associated with PJI in 267 serum samples.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>The IA was able to trace the dynamics of the pathogen-specific humoral immune response in all patients against PJI-related pathogens, prominently coagulase-negative staphylococci and streptococci. Pathogen-specific serum antibody titers declined in 62% of PJI patients over the course of treatment, while no changes in antibody titers were observed in 82% of Non-PJI patients during this study. Our serological data strongly suggested that antibody signatures reflect an immune response to microbial invasion.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>Our results provide insights into the pathophysiology of PJI and information on the individual disease courses. The IA is therefore a promising and novel serological tool of high resolution for monitoring the immunoproteomic footprints of infectious pathogens in the course of PJI.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Serology
lokal Female [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Prosthesis-Related Infections/immunology [MeSH]
lokal Middle Aged [MeSH]
lokal PJI
lokal Cohort Studies [MeSH]
lokal Periprosthetic joint infection
lokal Infection Array
lokal Antibody Formation [MeSH]
lokal Male [MeSH]
lokal Research
lokal Pilot Projects [MeSH]
lokal Pathogen-specific antibody response
lokal Antibodies, Bacterial/blood [MeSH]
lokal Prosthesis-Related Infections/microbiology [MeSH]
lokal Prosthesis-Related Infections/diagnosis [MeSH]
lokal Disease monitoring
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SmFueiwgVmlrdG9y|https://frl.publisso.de/adhoc/uri/UmFrb3csIEFuYXN0YXNpYQ==|https://frl.publisso.de/adhoc/uri/U2NocsO2ZGVyLCBMZW9uaWU=|https://frl.publisso.de/adhoc/uri/SG9mZXIsIEFuZHLDqQ==|https://frl.publisso.de/adhoc/uri/V2llYmUsIFNlcmdlag==|https://frl.publisso.de/adhoc/uri/U2Nob29uLCBKYW5vc2No|https://frl.publisso.de/adhoc/uri/V2Vpc3MsIFN0ZWZhbg==|https://frl.publisso.de/adhoc/uri/QnLDtmtlciwgQmFyYmFyYSBNLg==|https://frl.publisso.de/adhoc/uri/V2Fzc2lsZXcsIEdlb3JnaSBJLg==|https://frl.publisso.de/adhoc/uri/UmFhZmF0LCBEaW5h
1000 Hinweis
  • DeepGreen-ID: 97e2b56352ba436ba306ae5e2b3c04e6 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Research Network Molecular Medicine (FVMM) of the University Medicine Greifswald |
  2. Universitätsmedizin Greifswald |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Research Network Molecular Medicine (FVMM) of the University Medicine Greifswald |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Universitätsmedizin Greifswald |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6516122.rdf
1000 Erstellt am 2025-07-04T19:32:24.765+0200
1000 Erstellt von 322
1000 beschreibt frl:6516122
1000 Zuletzt bearbeitet 2025-08-15T19:58:13.381+0200
1000 Objekt bearb. Fri Aug 15 19:58:13 CEST 2025
1000 Vgl. frl:6516122
1000 Oai Id
  1. oai:frl.publisso.de:frl:6516122 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source